This review will focus on the different techniques and the long-term effects of the technique called myolysis on myoma growth. Indications for myolysis are essentially pelvic pain, compression symptoms and global uterine volume in order to avoid hysterectomy. In the late 1980s, myolysis was performed laparoscopically with the help of the neodynium: yttrium aluminium garnet (Nd:YAG) laser. Later, bipolar needles were developed as an alternative to the Nd:YAG laser. Diathermy and cryomyolysis were also proposed but series are small in the literature. Very recently, myoma interstitial thermo-therapy (MITT) was performed using the diode laser and a speci®c optical light diffuser that is designed to transmit laser light in all directions. Laparoscopic myolysis was proved to be effective in provoking myoma shrinkage, with a dramatic decrease in size and a marked devascularization of the myoma and this technique can be proposed as an alternative to myomectomy in selected patients: only those aged >40 years or those not desiring to bear any more children.
Introduction
Uterine ®broids are common, benign, solid tumours of the genital tract and, depending on their size and location, can lead to hysterectomy. In the early 1990s, advanced operative laparoscopy techniques have been developed and large uterine ®broids can now be removed laparoscopically in patients wishing to avoid hysterectomy (Daniell and Gurley, 1991; Dubuisson et al., 1991) . On the other hand, laparoscopic myolysis has been proposed in cases of subserous or intramural myomata as an alternative to myomectomy or hysterectomy. This technique was ®rst performed in the late 1980s in Europe. In fact, the concept of myolysis was ®rstly initiated by Donnez et al. (1989 Donnez et al. ( , 1990 for hysteroscopic myolysis and then applied to laparoscopic myolysis (Nisolle et al., 1993) . Initially, myoma coagulation was viewed as an alternative to myomectomy for women interested in preserving fertility. Using the energy of the neodymium:yttrium aluminium garnet (Nd:YAG) laser, leiomyomata were coagulated around the point of laser penetration, necrosing the myometrium, denaturing protein and destroying vascularity. No reports on the procedure appeared in the USA until Goldfarb reported his ®rst series (Goldfarb, 1992) . As an alternative to myomectomy and hysterectomy, the author performed myoma coagulation on leiomyomata up to 10 cm in diameter, but limited the procedure to post-reproductive and perimenopausal women.
Here, we evaluate the different techniques and the long-term effects of the technique called myolysis on myoma growth. Indications for myolysis are: (i) pelvic pain; (ii) compression symptoms; and (iii) global uterine volume (in comparison with pregnancy) at 9±12 weeks, in order to avoid hysterectomy (Nisolle et al., 1993) .
Myolysis was also considered as an alternative to laparoscopic myomectomy if myomectomy was judged to be too dif®cult or not mandatory, or in cases of multiple intramural myomata to avoid a time-consuming laparoscopic myomectomy.
The ®rst series of myolysis with Nd:YAG laser
In the late 1980s, myolysis was proposed to 48 women who were aged >35 years of age with intramural myomata up to 8 cm in diameter who did not wish to bear any more children (Nisolle et al., 1993 (Nisolle et al., , 1994 . The mean age of the women was 42 years (range 35±48 years). Myomata were diagnosed by pelvic examination.
Their size and location were con®rmed by ultrasonography. Vascularization was evaluated using Doppler ultrasound with colour¯ow imaging. No previous laparoscopy had been performed in these women.
Technique
Laparoscopy was performed transumbilically using a 10 mm endoscope adapted to a video camera. The instruments were introduced through three suprapubic punture sites (5 mm in diameter). The bare laser ®bre was introduced as perpendicularly as possible into the ®broid through a second puncture trocar to a depth depending on the myoma diameter. During the application of laser energy, the ®bre was introduced, reaching the central part of the ®broid, and was then removed slowly in order to provoke à strong coagulation'. The power used was 80 W. The procedure was repeated on the entire surface or the myoma in order to coagulate most of the myoma volume. The surface of the myoma was rinsed with 0.9% saline solution during the laser application to reduce thermal conduction through the uterine wall. The distance between holes was~5±7 mm.
Vasopressin (POR8; Sandoz, Brussels, Belgium) was never used to in®ltrate the myometrium adjacent to the ®broid to induce temporary myometrial ischaemia, reducing blood loss. However, in one case, diluted vasopressin was required to obtain complete uterine haemostasis: 5 IU of vasopressin in 20 ml of saline solution was injected just around the haemorrhagic site at the end of the procedure.
Immediately following myolysis, many laser scars can be seen on the myoma, which appears paler than normal. In the last 10 cases, an Interceed graft (Johnson and Johnson, New Brunswick, NJ, USA) was used to cover the coagulated area after haemostatic control was obtained, in order to decrease the risk of adhesions. Careful aspiration of peritoneal¯uid was then carried out and a suction catheter was left in the Pouch of Douglas.
In the ®rst series of 48 patients, none required laparotomy for bleeding, and no bladder or bowel injury was reported. During surgery, some problems arose because of dif®cult accessibility to posterior myomata by the laser ®bre, introduced through a second puncture. In such cases, the laser ®bre can be introduced directly through the laparoscope to achieve better accessibility.
The estimated blood loss was minimal (<50 ml) in all cases but one. The operating time varied from 20 to 45 min, depending on the myoma diameter and number. All patients were released in good physical condition the following day; none experienced any post-operative infection or haemorrhage.
Evaluation of myoma size
The number, size and location of the myomata were evaluated by vaginal echography before laparoscopic myolysis. The size of the myomata, measured by ultrasound, were 3±8 cm in diameter. Post-operatively, myoma evaluation was echographically performed at weeks 3, 6 and 12, after 6 months and after 1 year, 15 patients were evaluated after 3 years. Changes in the myoma structure and size were analysed by echography. In the ®rst 3 weeks, areas of necrosis were suspected by the presence of numerous anechogenic areas in the myoma. Subsequently, a more echogenic structure appeared.
Fibroids treated by myolysis ranged from 3 to 8 cm in diameter. The mean decrease in the myoma diameter after myolysis was 4% (range 0±6%) at week 6, 12% (range 2±18%) at week 12 and 41% (range 18±62%) after 6 months. The echostructure of the coagulated myoma was such that only experienced echographists could really distinguish the limits of the myoma.
The results observed after 1 year were similar to those seen after 6 months; there was neither any further decrease in size nor a regrowth of the myoma.
After 3 years, 15 patients were evaluated by echography. In 10 of them who had two to three myomata (3±5 cm in diameter), echography revealed only small areas (<1 cm in diameter) whose echographic structure was slightly different from the normal myometrium. Among the ®ve remaining patients, three were stable and two showed a reappearance of myomata in other sites. The two last patients underwent laparoscopic subtotal hysterectomy. Only a few adhesions were present. Failure of the treatment, indicated by an absence of any signi®cant decrease in the myoma diameter, was never observed.
Complications: adhesions con®rmed by second-look laparoscopy
In ®fteen patients, a second-look laparoscopy was carried out >6 months after myolysis for other reasons (ovarian cyst, sterilization, etc). The appearance of the myoma was made. In eight cases, dense and ®brous adhesions were observed between the myoma and, most frequently, the small bowel and/or epiploon. After adhesiolysis, the myoma appeared white without any apparent vessels. In two cases, we decided to remove the myoma. Dissection of the myoma from the normal myometrium was surprisingly easy and the myomata were removed in order to evaluate histologically the ef®cacy of myolysis. There was necrosis in most myoma areas, characterized by oedema and an absence of viable cells. In other areas, giant cells and macrophages containing carbonized particles very close to the necrotic sites suggested that necrosis was really induced by the laser coagulation. 
Myolysis with bipolar needles
Use of the Nd:YAG laser for myoma coagulation has certain disadvantages: the laser creates a large amount of smoke, which can obscure visibility. Inexpensive bipolar needles were developed as an alternative to the Nd:YAG laser. First used in Hamburg in 1993 by Adolphe Gallinat (Gallinat and Lueken, 1993) , the bipolar needles were short (1.5 cm) and appropriate only for smaller myomata. Two years later, another bipolar needle instrument was designed by Goldfarb in the USA (Goldfarb, 1995) . There are two forms of the bipolar instruments: (i) a 30 cm instrument with a 5 cm probe and (ii) a 45 cm probe that can be passed through the operating laparoscope. The 45 cm bipolar needles passed through the operating laparoscope enabled the surgeon to coagulate a posterior myoma. Using the bipolar instrument, thorough coagulation of a 7 cm leiomyoma could be achieved in 20 min.
In 150 procedures performed laparoscopically, no serious complications were reported as a result of using this instrument; however, one patient developed pelvic abscess and subsequently underwent hysterectomy. Another patient developed bacteraemia and made an uneventful recovery after antibiotic therapy (Goldfarb, 1992) .
The coagulating of the myoma with the bipolar needles devascularized the leiomyoma, resulting in leiomyoma shrinkage of 30±50% beyond the effect attributable to gonadotrophinreleasing hormone (GnRH) therapy.
Recent results in a series performed by Phillips (1995 Phillips ( , 1997 has con®rmed the ef®cacy of myoma coagulation. Prior to myoma coagulation, patients were pretreated with depot leuprolide. Leiomyomata were measured using a formula for the volume of an ellipsoid to achieve a volumetric evaluation of the leiomyoma before and after reduction. Within 6 months of surgery satisfactory results were achieved in 97.4% of patients. At 3±6 months after the operation, there was an 83.1% decrease in mean total uterine volume, an 88.5% reduction in mean total leiomyoma volume, and a 60% reduction in the mean longest leiomyoma diamater (compared with premedication measurements).
Myolysis with diathermy
One author (Chapman, 1993) reported on 18 patients with leiomyomata treated by myoma coagulation who were not ruled out if they wished to preserve fertility. Treatment involved exposing the myoma via laparotomy and then drilling holes with a carbon dioxide laser. To achieve coagulation, a diathermy electrode was inserted into each hole and the surrounding myoma was heated to achieve protein denaturation. Four of the 18 women subsequently became pregnant. Diathermy thus may be another promising method of treating myomata while minimizing adhesion formation.
Cryomyolysis
According to Zreik, cryomyolysis maintains at or slightly reduces myomata to post-GnRH agonist size, and all other uterine tissue returns to pretreatment size (Zreik et al., 1998) . The cryoprobe track was begun as a small hole through the uterine serosa with a monopolar needle.
The experience with cryomyolysis was limited to a prospective pilot study (Zreik et al., 1998) . A total of 14 patients were treated with a GnRH analogue for b2 months to decrease myoma size, with magnetic resonance imaging (MRI) being performed initially to determine shrinkage of the uterus. A second MRI was carried out 4 months after surgery and discontinuation of the GnRH analogue therapy, when regrowth of the uterus to its original size would be expected.
Myoma volume decreased by 6% over 4 months postoperatively in all 14 patients, with several patients having a decrease of >50%. Thus, it appears that reduction in myoma size by GnRH agonists can be prolonged or even enhanced by cryomyolysis, despite a return to the pretreatment size of normal uterine tissue. Four of the six women undergoing second-look of®ce laparoscopy had adhesion formation at freezing sites. Most were ®lmy and easily lysed at laparoscopy, but they were severe in one patient.
Myoma interstitial thermo-therapy (MITT)
Recently, Donnez et al. presented in Stockholm the ®rst cases of myoma treated by interstitial thermo-therapy using one speci®c laser ®bre, as has been described in endometrial laser intrauterine thermo-therapy (ELITT) procedure (Donnez et al., 1999a,b) . After having made a hole in the myoma serosa with the help of a trocar (1.5 mm), the laser ®bre was introduced in the myoma. The ®bre consists of an optical light diffuser that is designed to transmit laser light in all directions to effect the destruction of the myoma by hyperthermia. Although this new method seems to be very promising to avoid adhesions, long-term results on myoma growth are necessary before proposing this method for myolysis. The procedure employs a laser light to destroy the myoma by thermal therapy, increasing the temperature of the myoma to induce coagulation. The laser light is diffused inside the myoma in all directions. The 830 nm wavelength laser light penetrates the myoma wall to a precise depth, and it is absorbed by the haemoglobin. The absorbed light is then transformed to heat, it warms the myoma and causes controlled coagulation. The inherent light scattering inside the myoma contributes positively to the uniformity of the light distribution and resultant coagulation. A compact tabletop 20 W, 830 nm diode laser is available for this kind of surgery.
Reoperation and pregnancy
In the different studies published in the literature, the reoperation rate (hysterectomy) was found varying from 3±5% (Goldfarb, 1995) to 10% after 5 years (Donnez et al., 1999b) . Some authors have proposed this techniques in order to reduce the myoma size before pregnancy. In our group, we have always considered myolysis as a contra-indication. Although other authors (Chapman, 1993; Phillips, 1995) are in favour of pregnancy after myolysis, recent papers reporting cases of uterine rupture during pregnancy (Arcangeli and Pasquarette, 1997; Vilos et al., 1998) strongly suggest that myolysis is indicated only in women who do not desire further pregnancy.
Discussion
Myomata are very common in women of reproductive age and may be responsible for menorrhagia, anaemia, pelvic pain, compression, infertility or miscarriage. However, myomata are often asymptomatic and may not require treatment. In such asymptomatic patients, indications for myomectomy are debatable; therapy may be considered in some cases to prevent complications related to the growth of the myoma. Since the early 1990s, uterine ®broids can be treated endoscopically (Donnez et al., 1989 (Donnez et al., , 1990 Daniell and Gurley, 1991; Dubuisson et al., 1991; Nezhat et al., 1991) .
As previously described, in cases of submucosal uterine ®broids, hysteroscopic myomectomy (Donnez et al., 1989 (Donnez et al., , 1990 ) is carried out if the greater diameter of the leiomyoma is inside the uterine cavity. In cases of very large ®broids whose largest diameter is not inside the uterine cavity, the protruding portion is removed and the intramural portion is devascularized by introducing the laser ®bre into the myoma, at a length depending on the depth of the remaining intramural portion (Donnez et al., 1990 (Donnez et al., , 1993 . This technique proved to be effective in provoking myoma shrinkage, with a dramatic decrease in size and a marked devascularization of the myoma. This concept of myolysis was thus ®rstly described in hysteroscopic techniques in the late 1980s and then applied to the laparoscopic approach in the treatment of intramural myomas in women who do not desire further pregnancy (Nisolle et al., 1993) .
In cases of subserosal and intramural ®broids, myomectomy can also be carried out laparoscopically by an incision through the uterine serosa with a needle tip or knife electrode unipolar cautery, a potassium titanyl phosphate (KTP)/YAG laser in KTP mode, or hook scissors. The exposed ®broid is separated from the myometrium and removed by the combination of traction, twisting and cutting (Dubuisson et al., 1991) . Serosal reapproximation can be accomplished with a bipolar coagulator in cases of small ®broids (<3 cm), sutures or ®brin glue (Tissucol q ®brin sealant; Immuno AG, Vienna, Austria). The excised ®broids are removed from the abdominal cavity via a posterior colpotomy, through suprapubic anterior wall incisions or through the operating channel of the laparoscope after fragmentation, depending on the size of the tumour.
Sometimes, in cases of large intramural ®broids or multiple myomata, laparoscopic myomectomy can be dif®cult or timeconsuming (Nezhat et al., 1991) . Laparoscopic myolysis can be proposed as an alternative to myomectomy, performed by laparoscopy or laparotomy in cases of large or multiple intramural ®broids (Nisolle et al., 1993) . The ®broids are not removed but coagulated with the help of the YAG laser (Nisolle et al., 1993) , bipolar coagulation (Goldfarb, 1995 (Goldfarb, , 2000 , cryoprobe (Zreik et al., 1998) , monopolar coagulation (Chapman, 1993) and very recently diode laser (MITT) (Donnez et al., 1999 b) . The myoma coagulation is followed by necrosis and the size of the myoma decreases dramatically. The success of myolysis to treat myomata has been reported by many investigators (Goldfarb, 1992 (Goldfarb, , 1995a (Goldfarb, ,b, 2000 Chapman, 1993; Gallinat and Lueken, 1993; Nisolle et al., 1993 Nisolle et al., , 1994 Wood et al., 1994; Phillips, 1995) . The Nd:YAG laser was used for the ®rst time by Nisolle et al. (1993) and a decrease of 50% was found without regrowth of the myomata after 12 months. Since the ®rst report, all authors reported large series which have con®rmed the leiomyoma shrinkage of 30±50%.
With regard to cost-effectiveness, myolysis has the obvious economic bene®ts of outpatient surgery and rapid recovery and return to a normal life-style. Moreover, the subsequent reoperation rates for recurrence or persistence of symptoms are quite low.
The ®nal question is whether myolysis can be offered to women who wish to bear children. According to the literature, the issue is controversial. Published data have clearly demonstrated that viable pregnancies are possible after laparoscopic myolysis (Chapman, 1993; Wood et al., 1994; Phillips et al., 1995) , but the possibility of coagulation and devascularization of the myometrium exists, as does (at least theoretically), the possibility of uterine rupture in cases of pregnancy (Arcangeli and Pasquarette, 1997; Vilos et al., 1998) . The patients must thus be selected carefully: only those aged >40 years or those not desiring to bear any more children but wishing to avoid a future hysterectomy can undergo a myolysis.
Long-term follow-up has shown that there is no regrowth of the myoma (Nisolle et al., 1993 (Nisolle et al., , 1994 . Histology proved the complete devascularization of the myoma with subsequent necrosis. However, when performed, second-look laparoscopy demonstrated the presence of very dense adhesions in~10±50% of cases. In order to reduce the risk of adhesions, Interceed was placed on the coagulated area (Nisolle et al., 1993; Chapman, 1993; Phillips et al., 1995) . Randomized studies must be carried out in the future in order to prove the ef®cacy of Interceed in this situation.
In order to reduce adhesions, new laser ®bres, Interstitial Thermo-Therapy (ITT) ®bres (ESC Sharplan, Tel Aviv, Israel) are now being evaluated. In this type of ®bre, diffusion of the heat inducing the necrosis occurs along the terminal part of the ®bre. Only one hole is required and this reduces the lesion of the myoma serosa.
In conclusion, myolysis is effective in the reduction of myoma size and can be proposed as an alternative to myomectomy, but only in selected patients. Because of the risk of bowel adhesions and of coagulation of the myometrium, this type of surgery must be reserved for large, intramural, symptomatic myomata when endoscopic myomectomy is considered to be too dif®cult or timeconsuming.
